Expand LEGN Menu
LEGN MENU

LEGN Latest Press Releases

-- October 1, 2026 --

Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma Globe Newswire 9:00 AM

-- September 25, 2026 --

Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion Globe Newswire 7:00 AM

-- September 15, 2026 --

Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer Globe Newswire 8:00 AM

-- September 10, 2026 --

Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting Globe Newswire 8:00 AM

-- September 1, 2026 --

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference Globe Newswire 8:00 AM

-- August 11, 2026 --

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights Globe Newswire 7:00 AM

-- July 28, 2026 --

Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results Globe Newswire 8:00 AM

-- July 27, 2026 --

Legend Biotech Announces CEO Transition Globe Newswire 6:00 AM

-- June 23, 2026 --

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors Globe Newswire 8:00 AM

-- June 17, 2026 --

Legend Biotech Corporation Announces Pricing of Public Offering Globe Newswire 9:21 PM
Legend Biotech Corporation Announces Proposed Public Offering Globe Newswire 4:29 PM

-- June 14, 2026 --

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Globe Newswire 3:15 AM

-- June 2, 2026 --

Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL) Globe Newswire 9:30 AM

-- June 1, 2026 --

Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI Data in Multiple Myeloma at ASCO 2026 Globe Newswire 10:00 AM

-- May 21, 2026 --

Legend Biotech Announces Presentations at ASCO 2026 Globe Newswire 5:00 PM

-- May 12, 2026 --

Legend Biotech Reports First Quarter 2026 Results and Recent Highlights Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes